| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2017 ( Subtotal = $0 ) |
| 2017 | 2014 | ADVANCED DIAMOND TECHNOLOGIES, INC. | 48 E BELMONT DR | ROMEOVILLE | IL | 60446-1764 | WILL | USA | R44HL108534 | NIH Phase II-UNCD as Bio-Inert Interface for Anti-Thrombogenicity Applications in | 000 | 3 | NIH | 1/18/2017 | $0 |
|
 | Issue Date FY: 2014 ( Subtotal = $387,907 ) |
| 2014 | 2014 | ADVANCED DIAMOND TECHNOLOGIES INC | 429B WEBER ROAD | CRESTWOOD | IL | 60445 | COOK | USA | R44HL108534 | NIH Phase II-UNCD as Bio-Inert Interface for Anti-Thrombogenicity Applications in | 000 | 3 | NIH | 7/23/2014 | $387,907 |
|
 | Issue Date FY: 2013 ( Subtotal = $796,047 ) |
| 2013 | 2013 | ADVANCED DIAMOND TECHNOLOGIES INC | 429B WEBER ROAD | CRESTWOOD | IL | 60445 | COOK | USA | R43ES022344 | A HIGHLY MULTIPLEXED, SCALABLE ULTRANANOCRYSTALLINE DIAMOND MICROARRAY SENSOR FOR | 000 | 1 | NIH | 2/11/2013 | $249,922 |
| 2013 | 2013 | ADVANCED DIAMOND TECHNOLOGIES INC | 429B WEBER ROAD | CRESTWOOD | IL | 60445 | COOK | USA | R44HL108534 | NIH Phase II-UNCD as Bio-Inert Interface for Anti-Thrombogenicity Applications in | 000 | 2 | NIH | 9/17/2013 | $546,125 |
|
 | Issue Date FY: 2012 ( Subtotal = $149,430 ) |
| 2012 | 2012 | ADVANCED DIAMOND TECHNOLOGIES INC | 429B WEBER ROAD | CRESTWOOD | IL | 60445 | COOK | USA | R43AA021072 | ULTRANANOCRYSTALLINE DIAMOND MICROARRAY BIOSENSOR FOR NEUROCHEMICAL DETECTION | 000 | 1 | NIH | 5/14/2012 | $149,430 |
| 2012 | 2011 | ADVANCED DIAMOND TECHNOLOGIES INC | 429B WEBER ROAD | CRESTWOOD | IL | 60445 | COOK | USA | R43MH094121 | NIH SBIR PHASE I: DEVELOPMENT OF A NOVEL BORON-DOPED ULTRANANOCRYSTALLINE DIAMOND | 000 | 1 | NIH | 3/3/2012 | $0 |
|
 | Issue Date FY: 2011 ( Subtotal = $297,903 ) |
| 2011 | 2011 | ADVANCED DIAMOND TECHNOLOGIES INC | 429B WEBER ROAD | CRESTWOOD | IL | 60445 | COOK | USA | R43MH094121 | NIH SBIR PHASE I: DEVELOPMENT OF A NOVEL BORON-DOPED ULTRANANOCRYSTALLINE DIAMOND | 000 | 1 | NIH | 5/4/2011 | $148,086 |
| 2011 | 2011 | ADVANCED DIAMOND TECHNOLOGIES INC | 429B WEBER ROAD | CRESTWOOD | IL | 60445 | COOK | USA | R43HL108534 | NIH SBIR PHASE I: UNCD AS BIO-INERT INTERFACE FOR ANTI-THROMBOGENICITY APPLICATI | 000 | 1 | NIH | 5/15/2011 | $149,817 |
|
|